Mizuho Medy Co (TSE:4595) Owner Earnings per Share (TTM): 79.41 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4595 Mizuho Medy Co Ltd TSE:4595
80 GF Score
Price 円1,711.00
GF Value 円1,348.63
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Mizuho Medy Co Owner Earnings per Share (TTM)?

Mizuho Medy Co TSE:4595 -0.23% 80 Owner Earnings per Share (TTM) is 79.41 as of Dec. 2025. GuruFocus rates TSE:4595 with a GF Score™ of 80/100 and a GF Value™ of 円1,348.63 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 460 Drug Manufacturers companies, Mizuho Medy Co ranks better than 52.83% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Mizuho Medy Co's Owner Earnings per Share (TTM) ended in Dec. 2025 was 円79.41. It's Price-to-Owner-Earnings ratio for today is 21.55.


The historical rank and industry rank for Mizuho Medy Co's Owner Earnings per Share (TTM) or its related term are showing as below:

TSE:4595' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.81   Med: 21.47   Max: 173.21
Current: 21.92


During the past 12 years, the highest Price-to-Owner-Earnings ratio of Mizuho Medy Co was 173.21. The lowest was 3.81. And the median was 21.47.


TSE:4595's Price-to-Owner-Earnings is ranked better than
52.83% of 460 companies
in the Drug Manufacturers industry
Industry Median: 23.195 vs TSE:4595: 21.92

Mizuho Medy Co's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was 円0.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was 円170.59. It's PE Ratio (TTM) ratio for today is 10.03.

Mizuho Medy Co's EPS without NRI for the three months ended in Jun. 2026 was 円0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was 円170.59. It's PE Ratio without NRI ratio for today is 10.03.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Mizuho Medy Co Owner Earnings per Share (TTM) Related Terms


Mizuho Medy Co Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Mizuho Medy Co's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mizuho Medy Co Owner Earnings per Share (TTM) Chart

Mizuho Medy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.65 300.93 262.95 179.11 79.41

Mizuho Medy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 79.41 0.00 0.00

TSE:4595 vs ZTS: Owner Earnings per Share (TTM) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mizuho Medy Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mizuho Medy Co Price-to-Owner-Earnings vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mizuho Medy Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Mizuho Medy Co's Price-to-Owner-Earnings falls into.


TSE:4595
80GF Score
Mizuho Medy Co Ltd TSE:4595
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mizuho Medy Co Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Mizuho Medy Co's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 3,425
Depreciation, Depletion and Amortization 266
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 220
Change In Working Capital -1,958
Shares Outstanding (Diluted Average) 19

1. Start with "Net Income" from income statement. Mizuho Medy Co's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was 円3,425 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Mizuho Medy Co's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2025 was 円266 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Mizuho Medy Co's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = 円220 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Mizuho Medy Co's 5-Year Average Maintenance Capital Expenditure = 円220 Mil

5. "Change In Working Capital" is from cashflow statement. Mizuho Medy Co's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2025 was 円-1,958 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Mizuho Medy Co's Shares Outstanding (Diluted Average) for the months ended in Dec. 2025 was 19.049 Mil.

Mizuho Medy Co's Onwer Earnings Per Share for Dec. 2025 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 3425 +266+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-220.2832+-1958)/19.049
=79.41

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=1711.00/79.41
=21.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 79.41 mean?
Mizuho Medy Co (TSE:4595) has a Owner Earnings per Share (TTM) of 79.41 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Mizuho Medy Co. According to the industry distribution chart, Mizuho Medy Co ranks #217 out of 460 companies in the Drug Manufacturers industry, placing it in the top 47.2%.
Is Mizuho Medy Co's Owner Earnings per Share (TTM) too high?
Mizuho Medy Co's current Owner Earnings per Share (TTM) is 79.41. The Drug Manufacturers industry median Owner Earnings per Share (TTM) is 23.20. Mizuho Medy Co's value of 79.41 is 242.4% above this industry median. Based on the distribution chart, Mizuho Medy Co ranks #217 out of 460 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Mizuho Medy Co has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mizuho Medy Co's Owner Earnings per Share (TTM) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mizuho Medy Co ranks #217 out of 460 companies for Owner Earnings per Share (TTM). This puts Mizuho Medy Co in the upper half of its industry. The industry median Owner Earnings per Share (TTM) is 23.20. Mizuho Medy Co's value of 79.41 is 242.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Drug Manufacturers company?
The median Owner Earnings per Share (TTM) among Drug Manufacturers companies is 23.20, based on 460 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mizuho Medy Co's current Owner Earnings per Share (TTM) of 79.41 is 242.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Mizuho Medy Co. For the Drug Manufacturers industry, the median Owner Earnings per Share (TTM) is 23.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mizuho Medy Co's current Owner Earnings per Share (TTM) is 79.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mizuho Medy Co stock overvalued right now?
Based on GuruFocus' analysis, Mizuho Medy Co (TSE:4595) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,348.63, compared to a current price of 円1,711.00 — trading 26.9% above its estimated fair value. The current Owner Earnings per Share (TTM) is 79.41 and 242.4% above the Drug Manufacturers industry median of 23.20. Mizuho Medy Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Mizuho Medy Co (TSE:4595), the current Owner Earnings per Share (TTM) is 79.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mizuho Medy Co (TSE:4595) Overvalued in 2026?

Based on GuruFocus' analysis, Mizuho Medy Co stock appears to be overvalued. The current stock price of 円1,711.00 is trading 26.9% above its estimated GF Value™ of 円1,348.63. GuruFocus considers Mizuho Medy Co to be Modestly Overvalued.

Key valuation signals for TSE:4595:

  • Owner Earnings per Share (TTM): 79.41
  • GF Value™: 円1,348.63 vs. price of 円1,711.00 (26.9% above fair value)
  • GF Score™: 80/100 with 3 warning signs
  • Industry Position: 242.4% above the Drug Manufacturers median (#217 of 460)

No single metric tells the full story. See the TSE:4595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mizuho Medy Co Business Description

Address 5-4 Fujinoki-machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture, and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including a digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
80GF Score

Get the complete analysis for TSE:4595

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,711.00
Price
円1,348.63
GF Value